Fundraising FoxKendall Capital Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
BoardDavid Zhu(Director)in
Board seatRobert Langer· per SEC Form D
Co-investorsBeresford VenturesCatalytic Impact FoundationEMV CapitalHackensack Meridian Health Bear's DenLifespan Vision VenturesMEDA Angels+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.